Shanghai Pharma plans to buy pharmaceutical technology company for 588 million yuan
-
Last Update: 2020-05-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
June 16, according to Hong Kong media, Shanghai Pharmaceutical announced that it intends to pay 537.9 million yuan in cash (RMB, the same below), to Buy 50% of Xinhai Fengyuan from Inner Mongolia Yili Energy, Shaanxi Huaxin 70% equity, pharmaceutical 100% of the shares, and intends to pay 50.59 million yuan in cash, to Shaanxi Huaxin management to buy 15% of Shaanxi Huaxin shares, is the transaction price totalling 588 million yuan. Is the transaction needs to be approved by yili energy shareholders' meeting and approved for the record by the transferee's state-owned regulatory authority, the final transaction price shall be subject to the state-owned assets assessment for the record Responsible Editor:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
![[4-methylsulfonyl-2-(trifluoromethyl)phenyl]boronic acid](https://file.echemi.com/fileManage/upload/goodpicture/20210823/m20210823171652704.jpg)
